-
Signature
-
/s/ Sarah I. Rubenfeld, by Power of Attorney
-
Issuer symbol
-
HAL
-
Transactions as of
-
23 Jan 2026
-
Net transactions value
-
-$602,624
-
Form type
-
4
-
Filing time
-
26 Jan 2026, 11:19:37 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Miller Jeffrey Allen |
Director, President & CEO, Director |
3000 N. SAM HOUSTON PARKWAY E., HOUSTON |
/s/ Sarah I. Rubenfeld, by Power of Attorney |
26 Jan 2026 |
0001558667 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
HAL |
Common Stock |
Options Exercise |
$5,382,528 |
+171,200 |
+16% |
$31.44 |
1,272,443 |
23 Jan 2026 |
Direct |
|
| transaction |
HAL |
Common Stock |
Sale |
$5,985,152 |
-171,200 |
-13% |
$34.96 |
1,101,243 |
23 Jan 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
HAL |
Option to Buy Common Stock |
Options Exercise |
$0 |
-171,200 |
-100% |
$0.000000 |
0 |
23 Jan 2026 |
Common Stock |
171,200 |
$31.44 |
Direct |
F2 |
| holding |
HAL |
Option to Buy Common Stock |
|
|
|
|
|
128,500 |
23 Jan 2026 |
Common Stock |
128,500 |
$43.38 |
Direct |
|
| holding |
HAL |
Option to Buy Common Stock |
|
|
|
|
|
69,500 |
23 Jan 2026 |
Common Stock |
69,500 |
$53.54 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: